CAS 38136-70-8: Brevianamide F

Brevianamide F is an alkaloid compound, which is a secondary metabolite derived from certain fungal species, particularly from the genus *Penicillium*. This natural product is biosynthesized via complex enzymatic pathways within the fungi. The mode of action of Brevianamide F involves interaction with biological macromolecules, potentially disrupting or modulating various cellular processes. Research suggests it may possess biological activities such as antimicrobial, antifungal, and potentially cytotoxic properties. In scientific investigations, Brevianamide F is predominantly explored for its potential as a lead compound in drug discovery, given its unique structural features and biological effects. It serves as a subject of interest in the fields of organic chemistry and pharmacology, where its synthesis, biosynthesis, and potential therapeutic applications are actively studied. Further research into Brevianamide F may uncover new applications in medicinal chemistry, especially as a template for designing new therapeutic agents targeting pathogenic microorganisms or cancer cells.

(3S,8As)-3-((1H-Indol-3-Yl)Methyl)Hexahydropyrrolo[1,2-A]Pyrazine-1,4-Dione

Brevianamide F (Cyclo(L-Pro-L-Trp)), also known as cyclo-(L-Trp-L-Pro), belongs to a class of naturally occurring 2,5-diketopiperazines.

Applications Brevianamide F is used in the preparation, reactions, medicinal and cheical propreties of diketopiperazines as bioactive natural products. Acts as a reagent in the total synthesis and antitumor activity in vitro of glioperazine C and its derivatives, synthesis and biological evaluation of a post-synthetically trp-based diketopiperazine and it’s antitumor structure-activity relationship. References Wang, P., et al.: J. Chem. Pharma. Res., 7, 85 (2015); Preciado, S., et al.: MedChemComm, 4, 1171 (2013); Borthwick, A. D., et al.: Chem. Rev., 112, 3641 (2012)

Brevianamide F